Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Age differences in depression, anxiety, and cognitive dysfunction among people with multiple sclerosis

FY 2023-24

Summary
Multiple sclerosis (MS) is an inflammatory neurological condition that affects approximately 1 in 400 Canadians and causes a diverse range of symptoms. Often under-recognized and insufficiently addressed, between 40-90% of people with MS have cognitive impairment, with most studies describing a higher prevalence in older adults. Cognitive dysfunction can lead to social isolation, unemployment, and worsened quality of life. It is thus vital to identify causes of cognitive impairment, particularly for older adults with MS. Depression and anxiety - both common in MS - may be two treatable contributors to cognitive dysfunction. In prior research, we identified that depression, especially with anxiety, is an independent predictor of cognitive impairment among people with MS. However, it remains unclear whether the relationships between depression, anxiety, and cognition differ depending on the age of the person with MS. This is particularly important because with the use of disease-modifying therapies, people with MS are aging; and yet, much less research is conducted involving older adults with MS. In my proposed research, I aim to evaluate whether there are age differences in how depression and anxiety influence cognition in people with MS. In routine clinical care, over 800 people with MS who attended a Canadian neuropsychiatry clinic completed validated scales to assess depression and anxiety, and engaged in comprehensive cognitive testing. This data will be used for the statistical analyses in this research project. It is currently unknown whether treating depression and anxiety would improve cognition for older adults with MS. I hope that the findings from my study will support investigations to answer this question, enhancing the quality of care for people with MS.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506045
Name
Freedman David E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Age differences in depression, anxiety, and cognitive dysfunction among people with multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Anxiety; Cognition; Depression; Multiple Sclerosis; Neuropsychology; Older Adults
Abstract
Multiple sclerosis (MS) is an inflammatory neurological condition that affects approximately 1 in 400 Canadians and causes a diverse range of symptoms. Often under-recognized and insufficiently addressed, between 40-90% of people with MS have cognitive impairment, with most studies describing a higher prevalence in older adults. Cognitive dysfunction can lead to social isolation, unemployment, and worsened quality of life. It is thus vital to identify causes of cognitive impairment, particularly for older adults with MS. Depression and anxiety - both common in MS - may be two treatable contributors to cognitive dysfunction. In prior research, we identified that depression, especially with anxiety, is an independent predictor of cognitive impairment among people with MS. However, it remains unclear whether the relationships between depression, anxiety, and cognition differ depending on the age of the person with MS. This is particularly important because with the use of disease-modifying therapies, people with MS are aging; and yet, much less research is conducted involving older adults with MS. In my proposed research, I aim to evaluate whether there are age differences in how depression and anxiety influence cognition in people with MS. In routine clinical care, over 800 people with MS who attended a Canadian neuropsychiatry clinic completed validated scales to assess depression and anxiety, and engaged in comprehensive cognitive testing. This data will be used for the statistical analyses in this research project. It is currently unknown whether treating depression and anxiety would improve cognition for older adults with MS. I hope that the findings from my study will support investigations to answer this question, enhancing the quality of care for people with MS.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Freedman, David E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~